Fosun International LTD Amicus Therapeutics, Inc. Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$8.02 - $13.25 $5.95 Million - $9.83 Million	-741,969 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$10.96 - $14.4 $1.75 Million - $2.3 Million	160,000 Added 27.49%	741,969 $8.9 Million
Q1 2019 May 10, 2019	BUY	$10.04 - $13.92 $481,919 - $668,160	48,000 Added 8.99%	581,969 $7.82 Million
Q4 2018 Jan 31, 2019	BUY	$8.38 - $13.44 $998,669 - $1.6 Million	119,173 Added 28.73%	533,969 $4.96 Million
Q3 2018 Nov 09, 2018	BUY	$11.6 - $16.54 $4.81 Million - $6.86 Million	414,796 New	414,796 $5.09 Million

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.